Diagnostic impact of cerebrospinal fluid biomarker (pre-)analytical variability in Alzheimer’s disease
Manuscript Number:
15-0953R1
Author(s):
Peter Paul De Deyn, Sebastiaan Engelborghs, Johan Goeman, Joery Goossens, Jean-Jacques Martin, Ellis Niemantsverdriet, Hanne Struyfs, Hugo Vanderstichele
Disclosures
Peter Paul De Deyn
Consulting Fees:
Consulting function for Johnson and Johnson, Janssen Research Foundation